Cardio Diagnostics Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Cardio Diagnostics Holdings, Inc. on February 19, 2026. The filing serves as a Regulation FD disclosure regarding an investor conference call held on the same date at 3:00 p.m. Central Standard Time. The Company is an emerging growth company incorporated in Delaware, with its principal executive offices in Chicago, Illinois.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on the announcement of an investor event rather than the release of financial statements.
Material Changes
No material financial changes versus prior periods are disclosed in this document. The filing announces the discussion of recent clinical data, reimbursement progress, and strategic initiatives during the investor call.
Guidance, Outlook, and Risks
Management discussed corporate updates, recent clinical data, reimbursement progress, and long-term objectives during the call. The presentation materials and remarks contain forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially. These risks are detailed in the Company's most recent Form 10-K and Form 10-Q filings. The Company explicitly states it undertakes no obligation to update forward-looking statements except as required by law.
Key Facts for Investor Verification
- Verify the content of the Investor Presentation (Exhibit 99.1) for specific clinical data and strategic details.
- Review the replay of the investor call available at the Company's investor relations website for management commentary.
- Consult the most recent Form 10-K and Form 10-Q for detailed financial metrics and risk factors referenced in this filing.
- Note that the information in this 8-K and its exhibits is not deemed "filed" under Section 18 of the Exchange Act.